Doing Well by Doing Good: Life Science in the 21st Century October 27, 2009

Has bioscience lived up to its expectation as the next best thing in medicine?

At the dawn of the biotech era, investing in "new biology" was all about the tools of science and the promise of turning genes intro drugs. Now, more than 30 years later, there are over 300 biotech companies and several blockbuster drugs have been developed from their efforts. But what has made a real difference in these achievements? Venture capitalist (MPM Capital) and former Genentech scientist Bill Greene will discuss the accomplishments of bioscience so far and what bioscience is doing to address our personal and global needs.

Members $8, Non-members, $15, students, $7.

Official Website: http://tickets.commonwealthclub.org